Document is current
Any future updates will be listed below
-
Authors
Hou, Panpan http://orcid.org/0000-0001-7694-2262
Kang, Po Wei
Kongmeneck, Audrey Deyawe
Yang, Nien-Du http://orcid.org/0000-0002-5261-7382
Liu, Yongfeng
Shi, Jingyi
Xu, Xianjin
White, Kelli McFarland
Zaydman, Mark A.
Kasimova, Marina A. http://orcid.org/0000-0002-7497-9448
Seebohm, Guiscard
Zhong, Ling
Zou, Xiaoqin
Tarek, Mounir
Cui, Jianmin
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01 NS092570)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01 HL126774)
American Heart Association (18POST34030203)
- License Information
-
More Information
Article History
Received: 17 September 2019
Accepted: 18 December 2019
First Online: 3 February 2020
Competing interests
: J.S. and J.C. are cofounders of a startup company VivoCor LLC, which is targeting <i>I</i><sub>Ks</sub> for the treatment of cardiac arrhythmia. Other authors declare they have no competing interests.
